Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 3/6/24 → 3/6/26 |
Financiación
- Genmab US Incorporated: 27.556,00 US$
23-MULTI-64-GUI-PMC (GCT1042-01): A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors
- Arnold, Susanne M (PI)